• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Isis Pharmaceuticals Inc - Articles and news items

ionis

Isis Pharmaceuticals becomes Ionis Pharmaceuticals

Industry news / 18 December 2015 / Victoria White

Explaining his reasoning behind the company name change, Stanley Crooke, CEO of Ionis, told Forbes: “My underlying concern was that the name was a distraction”…

ISIS-FXI-Rx

Isis Pharmaceuticals initiates Phase 2 study of ISIS-FXI Rx in ESRD

Industry news / 30 October 2015 / Victoria White

The Phase 2 study is intended to further characterise the profile of ISIS-FXI Rx and will provide essential data for Bayer’s future clinical development programme for ISIS-FXI Rx…

Biogen Idec logo

Biogen Idec and Isis Pharmaceuticals announce strategic collaboration to advance treatment of neurological disorders

Industry news, News / 9 September 2013 / Biogen Idec

Biogen Idec and Isis Pharmaceuticals, Inc. announced that the companies have entered into a broad, multi-year collaboration…

Genzyme logo

Genzyme and Isis announce FDA approval of KYNAMRO™ injection for the treatment of HoFH

Industry news, News / 29 January 2013 / Sanofi

“Today’s FDA approval of KYNAMRO is great news…”

Genzyme logo

Genzyme and Isis provide update on CHMP opinion on KYNAMRO™ (mipomersen)

Industry news, News / 14 December 2012 / Sanofi

“We are disappointed by the Committee’s recommendation…”

AstraZeneca

AstraZeneca and Isis Pharmaceuticals form strategic alliance on RNA therapeutics for cancer

Industry news, News / 11 December 2012 / AstraZeneca

AstraZeneca and Isis Pharmaceuticals, Inc. announced a strategic alliance…

Sanofi

FDA Advisory Committee recommends KYNAMRO™ for homozygous familial hypercholesterolemia

Industry news, News / 18 October 2012 / Sanofi

“We are very encouraged by the support for KYNAMRO…”

Biogen Idec logo

Biogen Idec and Isis announce global collaboration for antisense program targeting myotonic dystrophy

Industry news, News / 29 June 2012 / Biogen Idec

Isis expands its rare disease franchise to include DM1…

Biogen Idec logo

Biogen Idec and Isis Pharmaceuticals announce global collaboration

Industry news, News / 4 January 2012 / Biogen Idec

Biogen Idec and Isis Pharmaceuticals, Inc. have entered into an exclusive, worldwide option and collaboration agreement…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +